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A green, straightforward and rapid method of synthesizing silver nanoparticles in an aqueous medium has been 
developed using Syzygium jambos (L.) Alston (Bogi Jamu) leaves extract and aqueous AgNO3 solution. The silver 
nanoparticles were characterized by UV–vis spectroscopy, transmission electron microscopy, X-ray diffraction and scanning 
electron microscopy. The results indicate the formation of spherical, nano-sized particles, with average particle size of  
20 nm based on TEM analysis. The Ag-nanoparticles efficiently catalyze the synthesis of 2-substituted benzimidazoles by 
the reaction of aldehydes with o-phenylenediamine in DMSO at room temperature. Simple workup, mild reaction 
conditions, low cost, easy separation, and reusability of the catalyst are some advantages of this method. 
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2-Aryl benzimidazoles and their derivatives have 
received extensive interest in diverse areas of 
chemistry as these structural motifs are the main 
constituent in numerous pharmaceutical agents 
possessing a wide range of biological applications1 
such as antihistamine, antiulcer agents, topoisomerase 
inhibitors2, anticancer3, antihypertensive4, antimicrobial5 
drugs. Also, 2-aryl benzimidazole derivatives are 
industrially used as fluorescent acid-base indicators6, 
dopants for plastic scintillation applications7 and 
subunits of polybenzimidazoles as thermally stable 
polymers8. Due to their biological and industrial 
importance and wide applications, the synthesis of 
these benzimidazole derivatives has been extensively 
studied in synthetic organic chemistry in recent years. 
In all of the reported procedures, two main synthetic 
routes could be observed; one route in general 
involves direct coupling of a carboxylic acid  
or carboxylic acid derivatives with an appropriate  
o-phenylenediamine under the influence of a strong 
acid such as hydrochloric acid9 or polyphosphoric 
acid10 at high temperature or under microwave 
irradiation11. The second route involves a two-step 
procedure that includes the oxidative cyclo-
dehydrogenation of Schiff bases, which are often 
generated from the condensation of o-phenylene-
diamines and aryl aldehydes. The direct condensation 
of o-aryldiamines and aromatic aldehydes at room 
temperature is less developed because as previously 
reported this apparently simple reaction is a complex 
sequence of competing reactions and leads to the 
formation of a complex mixture of products 
containing 1,2-disubstituted benzimidazoles and  
1,2-disubstituted benzimidazolines as main byproducts12. 
Therefore, in the second route various oxidative and 
catalytic reagents have been employed13-23. The main 
drawback of these methods is that a large part of the 
catalyst is not recoverable and is destroyed in the 
work-up procedure.  
However in recent years, many heterogeneous 
catalysts, viz., animal bone meal,24 FeCl3-doped 
polyaniline nanoparticles,25 CuO nanoparticles 
supported on silica26, etc. have been reported for the 
synthesis of 2-aryl benzimidazole derivatives. These 
synthetic organic routes using heterogeneous catalysts 
have advantages over their counterparts like ease of 
handling of the catalyst, enhanced reaction rates, 
greater selectivity, simple work-up and recyclability 
of the catalyst27.  
Current advances in nanoscience and 
nanotechnology have also led to the expansion of an 
efficient synthesis of bioactive compounds using 
nanoparticles in an ecologically and economically 
favorable way which is an immense challenge in 
modern chemistry28. In our continuous search for a 
better catalyst for the synthesis of benzimidazoles in 
terms of operational simplicity, reusability, and 
economic viability, herein we report Ag-nanoparticles 




as a new and reusable heterogeneous catalyst, 
synthesized by using aqueous Syzygium jambos (L.) 
Alston (Bogi Jamu) leaves extract. This heterogeneous 
catalyst system exhibits an excellent catalytic activity 
and recyclability for the construction of the 2-aryl 
benzimidazoles framework. Moreover, synthesis of 
Ag-nanopaticles is easy, cheap and green. 
There are many reports on synthesis of Ag, Au,  
Pd nanoparticles using various plant leaves extracts29. 
To the best of our knowledge, this is the first synthetic 
report for the synthesis of silver nanoparticles using  
S. jambos (L.) Alston plant leaves extract and successfully 
utilized for synthesis of 2-arylbenzimidazoles at room 
temperature. 
 
Materials and Methods 
All the substituted aldehydes, diamines, DMSO, 
ethanol, ethyl acetate and hexane were obtained from 
Aldrich or Merck and used without further purification.  
 
Synthesis of Ag-nanoparticles 
Fresh leaves of S. jambos (L.) Alston (Bogi Jamu) 
were collected from the nearby areas of Dibrugarh 
University and washed thoroughly with distilled water 
and shade dried. Dried leaves (10 g) were crushed in a 
mortar into fine powder. 
Leaves extract of S. jambos (L.) Alston was 
prepared by taking 10 g of the powdered sample in 
100 mL deionised water and heated for 4 h at 40 °C. 
After cooling at room temperature, the solution was 
filtered and the filtrate was used for supplementary 
experiment. 
The S. jambos (L.) Alston leaves extract (2 mL) 
was added to 30 mL of 1 mM aqueous AgNO3 
solution (5.1 mg of AgNO3 in 30 mL water) and 
stirred at room temperature for 4 hours. The color of 
the reaction product turned dark brown due to the 
reduction of Ag+. Finally the reaction mixture was 
centrifuged and washed three times with distilled 
water to give 3.0 mg Ag nanoparticles (93% yield). 
The nanoparticles were characterized using UV-vis 
spectroscopy, FT-IR, XRD, SEM and TEM. 
 
Characterization 
The formation of nanoparticles was monitored  
by UV-vis spectroscopy recorded in the range 
between 200–900 nm using UV-1700 (Shimadzu) 
spectrophotometer. The Ag nanoparticles synthesized 
after 2–4 h of reaction with the S. jambos (L.) Alston 
leaves extract were centrifuged at 10,000 rpm for  
15 min to isolate the Ag-nanoparticles from other 
compounds present in the solution, followed by 
redispersion in sterile distilled water to remove any 
uncoordinated biological molecules. To ensure better 
separation, this process was repeated three times.  
The purified particles were then dried and the powder 
was characterized by FT-IR spectra recorded as  
KBr pellets on a Shimadzu IR-Prestige-21 FT-IR 
spectrophotometer operating from 400 to 4000 cm-1. 
The 1H NMR spectra of the sample were recorded on 
a Bruker Avance II 400 MHz spectrometer using 
TMS as an internal standard in DMSO-d6. Electronic 
absorption spectra were obtained with Shimadzu  
UV-1700 UV-vis spectrophotometer at room 
temperature. 
X-ray diffraction (XRD) patterns were obtained on 
a Rigaku X-ray diffractometer (model: ULTIMA IV, 
Rigaku, Japan) with Cu Kα X-ray source (λ = 1.54056 Å) 
at generator voltage of 40 V, generator current 40 mA 
with the scanning rate as 2° min−1. The SEM  
and TEM analysis were carried out to study the 
morphology, shapes and size of the nanoparticles 
using SEM (model 6390 LV JEOL Asia PTE Ltd., 
Singapore/JEOL JSM) and TEM (model TECNAI G2 
20 S-TWIN (200KV); Resolution: 2.4 Ǻ). 
 
General procedure for synthesis of 2-aryl benzimidazole: 
To a mixture of o-phenylenediamine (1.0 mmol) 
and aldehyde (1.0 mmol) in DMSO (2 mL), 5 mol% 
of Ag-nanoparticles catalyst were added. The 
resulting mixture was stirred at room temperature for 
appropriate time. After completion of the reaction as 
monitored by TLC, the reaction mixture was diluted 
with ethanol and centrifuged to separate the catalyst. 
To the reaction mixture, water was added to 
precipitate out the desired product which was filtered, 
washed several time with water and then dried. 
2-Phenyl-1H-benzimidazole (1): IR (KBr, cm-1): 
1620, 3444. 1H NMR (DMSO-d6): δH 7.14–7.25  
(m, 2H), 7.44–7.61 (m, 5H), 8.20 (d, 2H), 12.94  
(s, 1H); 13C NMR (DMSO-d6): δC 122.1, 126.4, 
128.4, 128.9, 129.2, 129.8, 130.1, 151.2. 
2-(4-Chlorophenyl)-1H-benzimidazole (2): IR 
(KBr, cm-1): 3350, 2920, 1630, 1600; 1H NMR 
(DMSO-d6): δC 12.90 (bs, 1H, NH), 8.18 (d, 2H), 
7.65-7.55 (m, 4H, arom.), 7.13-6.99 (m, 2H, 
arom.);13C NMR (DMSO-d6): δC 150.6, 134.9, 131.6, 
129.5, 129.2, 128.5. 
2-(2-Hydroxyphenyl)-1H-benzimidazole (3): IR 
(KBr, cm-1): 3325, 3043, 1604, 1530, 1489, 1279; 1H 
NMR (DMSO-d6): δC 12.92 (bs, 1H, NH), 8.06  
(d, 2H), 7.41-7.23 (m, 4H, arom.), 7.08–7.00  




(m, 2H, arom.), 5.39 (s, 1H, OH); 13C NMR (DMSO-
d6): δC 158.5, 152.2, 132.2, 126.7, 119.5, 117.6, 113.1. 
2-(2-Nitrophenyl)-1H-benzimidazole (5): IR (KBr, 
cm-1): 1338, 1516, 1620, 3421; 1H NMR (DMSO-d6): 
δH 13.05 ( bs, 1H, NH), 8.19-7.97 (m, 2H), 7.89-7.62 
(m, 2H), 7.52-7.26 (m, 4H); 13C NMR (DMSO-d6): 
δC 149.4, 147.7, 133.1, 131.3, 124.7, 124.6. 
2-(2-Chlorophenyl)-1H-benzimidazole (6): IR 
(KBr, cm-1): 3413, 1620, 1589, 1440, 1274, 1047, 
743. 1H NMR (DMSO-d6): δH 12.74 (s, 1H), 7.89-
7.92 (m, 2H), 7.51-7.67 (m, 4H), 7.20-7.24 (m, 2H); 
13C NMR (DMSO-d6): δC 149.5, 132.5, 132.0, 131.6, 
130.8, 130.4, 127.9. 
5-Nitro-2-phenyl-1H-benzimidazole (7): IR (KBr, cm-1): 
3377, 1625, 1519, 1335, 694, 735 1H NMR  
(DMSO-d6): δ H 7.57 (m, 2H), 7.59 (m, 1H), 7.74  
(d, 1H), 8.09-8.12 (m, 1H), 8.18-8.2 (m, 2H), 8.45  
(s, 1H), 13.60 (s, 1H). 13C NMR (DMSO-d6): δC 151.2, 
147.2, 143.5, 136.6, 132.2, 129.3, 127.5, 117.6, 113.3. 
2-(4-Chlorophenyl)-5-nitro-1H-benzo[d]imidazole 
(8): IR (KBr, cm-1): 3375, 1623, 1518, 1334, 692, 
736. 1H NMR (DMSO-d6): δH 10.01 (1 H, NH), 8.85 
(s, 1H), 8.12-8.04 (m, 2H), 7.95-7.91 (dd, 1H), 7.55-
7.39 (m, 2H); 13C NMR (DMSO-d6): δC 151.6, 148.2, 
143.8, 136.3, 135.4, 133.9, 131.5, 129.2, 128.6, 124.9. 
4-(5-Nitro-1H-benzo[d]imidazol-2-yl)phenol (9): 
IR (KBr, cm-1): 3377, 1622, 1524, 1333, 692, 735. 1H 
NMR (DMSO-d6): δH 13.34 (1H, NH), 8.47-8.44 (d, 
1H), 8.43 (s, 1H), 8.30-8.04 (m, 2H), 7.67-7.64 (d, 
1H), 6.97-6.84 (m, 2H), 5.60 (s, 1H, OH); 13C NMR 
(DMSO-d6): δC 152.6, 149.2, 140.8, 135.3, 134.4, 
133.9, 130.5, 129.2, 127.6, 122.9. 
5-Nitro-2-(2-nitrophenyl)-1H-benzo[d]imidazole (10): 
IR (KBr, cm-1): 3379, 1621, 1520, 1336, 696, 734. 1H 
NMR (DMSO-d6): δH 9.05 (1H, NH), 8.46-8.43  
(d, 1H), 8.10-8.09 (d, 1H), 8.00-7.75 (m, 5H); 13C 
NMR (DMSO-d6): δC 156.5, 151.4, 149.7,  
136.4, 140.0, 133.9, 132.4, 130.8, 130.3, 125.3,  
124.8, 114.1, 113.6. 
2-(5-Nitro-1H-benzo[d]imidazol-2-yl)phenol (11): 
IR (KBr, cm-1): 3377, 1622, 1524, 1333, 692, 735. 1H 
NMR (DMSO-d6): δH 12.90 (1H, NH), 8.37-8.34  
(d, 1H), 8.23 (s, 1H), 7.79-7.64 (m, 2H), 7.66-7.24 
(m, 3H), 5.50 (s, 1H, OH); 13C NMR (DMSO-d6): δC 
154.1, 152.6, 149.2, 140.8, 135.3, 134.4, 133.9, 130.5, 
129.2, 127.6, 122.9, 117.2, 113.1. 
2-(2-Chlorophenyl)-5-nitro-1H-benzo[d]imidazole 
(12): IR (KBr, cm-1): 3377, 1625, 1519, 1335, 694, 
735. 1H NMR (DMSO-d6): δH 9.01 (1H, NH),  
8.42 (s, 1H), 8.41-8.40 (d, 1H), 7.97-7.93 (m, 1H), 
7.58-7.39 (m, 4H); 13C NMR (DMSO-d6): δC 149.2, 
141.0, 139.6, 138.6, 132.7, 131.6, 130.9, 130.6, 130.0, 
128.6, 128.1, 128.1, 119.4. 
 
Results and Discussion 
 
Characterization of the Ag-nanoparticles 
The formation of Ag-nanoparticles was visually 
confirmed by color change from light yellow to dark 
brown which arises due to surface plasmon resonance 
phenomenon of the silver nanoparticles30. The 
formation of nanoparticle was monitored by recording 
the UV-vis spectra. Figure 1 shows the UV-vis 
spectra of silver nanoparticles after 4 h of reaction 
with a characteristics peak at 451 nm, which confirms 
the fairly rapid bio-reduction of Ag+ to Ag0 major part 
of the reduction of Ag+ ions wase completed within  
4 hs, after addition of the S. jambos (L.) Alston leaves 
extract to the metal ion solutions (Fig. 1). The inset  
of Fig. 1 shows the visible color change after 4 h 
during Ag-nanoparticles synthesis.  
The FT-IR analysis was carried out to identify  
the possible biomolecules responsible for the 
reduction of Ag+ ions and capping of the bioreduced 
Ag-nanoparticles synthesized by the S. jambos (L.) 
Alston leaves extract. Figure 2(a) shows the FT-IR 
spectrum of the Ag nanoparticles synthesized using  
S. jambos (L.) leaves extract. Ag nanoparticles 
formed by reduction of Ag+ ions using the leaves 
extract showed peaks at 3259 cm−1 (weak peak for 
OH vibration), 1680 cm−1, 1442 cm−1, 1557 cm−1, 
1515 cm−1, 1392 cm−1, 1090 cm−1, 1051 cm−1. The 
FTIR spectra of 2(b) only the aqueous extract of  
S. jambos (L.) Alston leaves shows the peaks at  
3248 cm−1 (strong peak for OH vibration),  
2095 cm−1, 1608 cm−1, 1409 cm−1, 1267 cm−1 and 
1092 cm−1. This result suggests the presence of 
flavonoid adsorbed on the surface of metal 
 
 
Fig. 1 – UV-vis spectrum of Ag-nanoparticles formed on reacting 
1 mM aqueous solution of AgNO3 with Syzygium jambos (L.) 
Alston leaves extract. [Inset: Formation of Ag-nanoparticles. 
Left: AgNO3 solution after addition of plant extract; 
Right: AgNO3 solution and plant extract after 4 h]. 




nanoparticles. The flavonoid and phenolic acids 
molecule play a major role in the synthesis of  
Ag-nanoparticles. Strong peak for OH vibration at 
3248 cm−1 in Fig. 2(b) is due to the presence of 
phenolic group and water present in the sticky part  
of the aqueous extract of respective plant material. 
The formation of the Ag-nanoparticles was further 
confirmed by the XRD analysis. The XRD patterns of 
Ag-nanoparticles using S. jambos (L.) Alston leaves 
extract are shown in Fig. 3. The diffraction peak  
at 2θ values of 38.10°, 44.16°, 64.52° and 77.40° are 
assigned to the (111), (200), (220) and (311) 
respectively of lattice plane of face centered cubic 
(fcc) for Ag-nanoparticle. The corresponding ‘d’ 
spacing of Ag-nanoparticles were 2.360, 2.0492, 
1.4431 and 1.2320 respectively. The high intensity 
diffraction peak observed at 38.10°, to Ag, confirmed 
that the nanoparticles were composed of pure 
crystalline Ag31. 
To study the size and shape of the prepared  
Ag-nanoparticles, SEM and TEM analysis were 
carried out. The SEM image (Fig. 4) confirmed that 
the Ag-nanoparticles exhibit spherical shape with  
the average size in the range of 0.60–0.70 µm.  
This SEM image also indicates that synthesized 
nanoparticles were not aggregated (monodisperse) 
and have high density as well as stability. 
TEM analysis was used to evaluate the morphology 
and size of some representative silver particles 
obtained. In Fig. 5, the TEM images show that the 
Ag-nanoparticles are well dispersed in colloidal 
solution with spherical particles of size 20 nm.  
 
Optimization of synthesis parameters 
We optimized various parameters including 
solvent, amount of catalyst and the reaction time for 
the reaction of o-phenylenediamine (1.0 mmol) with 
4-chlorobenaldehyde (1.0 mmol) as a model reactant 
(Scheme 1) and the resultant data are listed in Table 1. 
Various solvents were examined during the 




Fig. 2 – (a) FT-IR spectrum of Ag nanoparticles synthesized by reduction of Ag+ ion by Syzygium jambos (L.) Alston leaves extract, and, 




Fig. 3 – XRD pattern of Ag nanoparticles formed on reacting 
Syzygium jambos (L.) Alston leaves extract with AgNO3 solution. 
  
 
Fig. 4 – SEM image of the silver nanoparticles formed on reacting 
Szygium jambos (L.) Alston leaves extract with AgNO3 solution. 
 




reactions appeared to be largely dependent on the 
nature of the solvent. The data in Table 1 shows that 
amongst the five solvents investigated, viz. ethanol 
(EtOH), water (H2O), dimethyl sulfoxide (DMSO), 
N,N-dimethylformamide (DMF), acetonitrile (AcCN), 
and dimethyl sulfoxide (DMSO) was found to be the 
best. DMSO is an aprotic polar solvent and it seems 
especially well suited as a medium for C-heteroatom 
bond formation in transition metal catalysed organic 
reactions32. Herein we have used Ag nanoparticles as 
a catalyst and not a transition metal complex, and  
the exact role of DMSO is yet to be investigated.  
We prepared three batches of Ag-nanoparticles to 
optimize the reaction and got almost the same yield of 
the products in each batch. For the present studies  
5 mol% of Ag-nanoparticles was found to be the 
optimum amount of catalyst. In the absence of 
catalyst, no reaction takes place at room temperature. 
We also carried out a blank reaction using only plant 
extract at room temperature for 24 h, no reaction 
occurred for the blank reaction. The 2-arylated 
benzimidazole product was obtained in 95 % yield 
after stirring at room temperature in DMSO for 4 h. 
Finally, the conditions mentioned in entry 3 (Table 1) 
were chosen as the optimum condition for the 
synthesis of 2-arylated benzimidazole from  
o-phenylenediamine and 4-chlorobenaldehyde. 
After optimization to expand the synthetic scope of 
this protocol, the reaction was extended to various 
aldehyde and o-phenylenediamine derivatives. In all 
cases, reactions were completed in a reasonable time 
(4–12 h) and 2-aryl bezimidazole derivatives were 
formed in good yields (82% – 96%). The use of this 
protocol in the reaction of o-phenylenediamine with 
different aldehydes produced only one of the possible 



















Table 1 – Effect of various solvents in the condensation reaction of o-phenylenediamine (1.0 mmol) with 4-chlorobenzaldehyde 
(1.0 mmol) at room temperature using Ag-nanoparticles 
Entry Catalyst (mol %) Solvent Time (h) Yielda (%) TOFb (h-1) 
1 5 Ethanol 18 94 1.04 
2 5 Water 24 52 0.43 
3 5 DMSO 4 96 4.80 
4 5 DMF 8 90 2.25 
5 5 Acetonitrile 20 86 0.86 
6 3 DMSO 4 89 7.40 
7 1 DMSO 4 75 18.74 
8 7 DMSO 4 97 3.45 
9 No catalyst DMSO 24 No reaction - 
10 No catalyst Plant extract 24 No reaction - 
aIsolated yield. 
bTOF ( Turn Over Frequency) = mol of product /(time × mol of catalyst). 
 
 
Fig. 5 TEM image of the silver nanoparticles formed on reacting 
Szygium jambos (L.) Alston leaves extract with AgNO3 solution. 
 





One of the very important industrial applications  
of heterogeneous catalyst is its reusability. After 
completion of the reaction, the mixture was diluted 
with ethanol and centrifuged to separate the catalyst. 
Then it was washed with ethylacetate and the  
Ag-nanoparticles were reused. With almost consistent 
activity, the catalyst can be used up to four times. 
Even at the fourth run, the yield was 90%, signifying 




In the present study, Ag-nanoparticles were 
synthesized using S. jambos (L.) Alston leaves  
extract and found to be a cheap, air-stable and 
efficient recyclable catalyst for the synthesis of  
2-aryl benzimidazole derivatives by coupling of  
o-phenylenediamine with aldehyde in DMSO as a 
solvent at room temperature. The mild reaction 
conditions, short reaction time, high yields, easy and 
quick isolation of the products, recyclability of the 
catalyst, eco-friendly and good selectivity are the 
main advantages of this protocol. To the best  
of our knowledge, this is the first synthetic  
report for the synthesis of silver nanoparticles using  
S. jambos (L.) Alston leaves extract and successfully 
utilized for synthesis of 2-arylbenzimidazoles at  
room temperature.  
Table 2 – Ag-nanoparticles catalyzed synthesis of benzimidazole derivativesa 















































































9 86 1.91 
 
NH2
NH2O2N   





















10 84 1.68 
aReact. cond.: o-phenylenediamine: (1.0 mmol); aldehyde: (1.0 mmol); Ag-nano catalyst: (5 mol%) in DMSO (2 mL). 
bIsolated yield. 
cTOF ( Turn Over Frequency) = mol of product/ (time×mol of catalyst). 
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